(2S)-2-amino-N-[(3S,9S,14S,20S)-14-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3,20-bis[(4-fluorophenyl)methyl]-2,5,8,15,18,21-hexaoxo-11,12-dithia-1,4,7,16,19,22-hexazabicyclo[20.2.2]hexacosan-9-yl]-3-(4-hydroxyphenyl)propanamide 2,2,2-trifluoroacetic acid (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (2S)-2-amino-N-[(3S,9S,14S,20S)-14-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3,20-bis[(4-fluorophenyl)methyl]-2,5,8,15,18,21-hexaoxo-11,12-dithia-1,4,7,16,19,22-hexazabicyclo[20.2.2]hexacosan-9-yl]-3-(4-hydroxyphenyl)propanamide 2,2,2-trifluoroacetic acid's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
(2S)-2-amino-N-[(3S,9S,14S,20S)-14-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3,20-bis[(4-fluorophenyl)methyl]-2,5,8,15,18,21-hexaoxo-11,12-dithia-1,4,7,16,19,22-hexazabicyclo[20.2.2]hexacosan-9-yl]-3-(4-hydroxyphenyl)propanamide 2,2,2-trifluoroacetic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Kappa-type opioid receptor Protein (Entity type)	EC50
(2S)-2-amino-N-[(3S,9S,14S,20S)-14-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3,20-bis[(4-fluorophenyl)methyl]-2,5,8,15,18,21-hexaoxo-11,12-dithia-1,4,7,16,19,22-hexazabicyclo[20.2.2]hexacosan-9-yl]-3-(4-hydroxyphenyl)propanamide 2,2,2-trifluoroacetic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Mu-type opioid receptor Protein (Entity type)	Ki
(2S)-2-amino-N-[(3S,9S,14S,20S)-14-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3,20-bis[(4-fluorophenyl)methyl]-2,5,8,15,18,21-hexaoxo-11,12-dithia-1,4,7,16,19,22-hexazabicyclo[20.2.2]hexacosan-9-yl]-3-(4-hydroxyphenyl)propanamide 2,2,2-trifluoroacetic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Delta-type opioid receptor Protein (Entity type)	Ki